HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: COVID-19: Long-Term Effects

COVID-19: Long-Term Effects current awareness bulletin

Frequency: Fortnightly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To access articles, click on displayed links, and log in with your Healthcare Library number and password if prompted. For guidance on logging in, please go to: https://healthcarelibrary.qub.ac.uk/LogginginonTrustdevices/

To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk

Subscribers to this bulletin might also find LitCovid, and Memorial Sloan Kettering Library's COVID Impacts website, useful - see below for details.

LitCovid

LitCovid provides access to COVID-19 related records in PubMed. Content is updated daily. Click the link below for access.

COVID Impacts

Memorial Sloan Kettering Library curates an online guide to the long-term health and social impacts of COVID-19:

November 2025 (1)

Association between MASP2 gene polymorphisms and susceptibility to Covid-19 in Iranian patients: a case-control study

Association between vaccination status and clinical characteristics among young adults infected with COVID-19

Association of Azvudine with severe outcomes among hospitalized patients with COVID-19 during an omicron-dominance period in Wuhan, China: a single-center, retrospective, matched cohort study

Association of remdesivir treatment with long-term mortality after COVID-19 hospitalization

Care at home for remdesivir treatment of COVID-19: a survey study of patient and physician experiences

Chemotherapy and anti-CD20 monoclonal antibody impact on SARS-CoV-2 nucleic acid amplification tests in hematologic malignancies: a retrospective study

Clinical characteristics of patients with COVID-19-associated mucormycosis (CAM) hospitalized at Shafa Hospital, Kerman: 2022

Clinical outcomes and predictive modeling in COVID-19 patients with type 2 diabetes mellitus: a multicenter retrospective cohort study

Effect of anti-S antibody titers on newly confirmed cases of COVID-19 in Korea: a community-based cohort study (K-SEROSMART Wave 2)

Impact of prefecture-level intensive care unit congestion on mortality in severe COVID-19 patients: a retrospective observational study in Japan

Lactate/albumin ratio predicts mortality in critically ill COVID-19 patients: a retrospective machine learning study

Lessons and concerns about the SARS-CoV-2/DENV co-infection

Modeling the effectiveness of RT-PCR, RT-LAMP, and antigen testing strategies for COVID-19 control

Molnupiravir for treating COVID‐19 (new Cochrane intervention review)

Persistent pain and brain fog after COVID-19 infection in European adults aged 50 and over: a population-based longitudinal study

Prevalence and duration of common symptoms in people with long COVID

Risk factors of COVID-19 breakthrough infection: a case-control test-negative design study

Role of the alpha-1 antitrypsin in the progression and severity of COVID-19 infection among Saudi patients

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

Seroprevalence of COVID-19 neutralizing antibodies among multi-ethnic staff of an Asian primary healthcare institution: insights from point-of-care testing and implications for booster vaccination decisions

Study on the dynamic changes in antinuclear antibody spectrum in SARS-CoV-2 infection

Systemic increase of AMPA receptors associated with cognitive impairment of long COVID

Updated evidence for Covid-19, RSV, and influenza vaccines for 2025–2026

Sources

BMC Infectious Diseases (14th- 30th Oct); Brain Communications (Oct); Cochrane Library (Oct); Journal of Global Health (Oct); Nature (Oct); NEJM (Oct); Scientific Reports (Oct)

October 2025 (2)

Applicability and adaptation of cognitive behavior therapy for long COVID neuropsychiatric symptoms: a review with insights from ME/CFS

Association between mental health symptoms and autoimmunity in patients with long COVID

Association between SARS-CoV-2 levels in urban wastewater and reported COVID-19 cases in Changsha, Central China

Bioinformatics analysis of the proteome in the pathway of complement and coagulation cascades in COVID-19: discovering potential biomarkers of FGB and SERPINA5

Chronic cardiovascular disorders associated with COVID-19: a literature review

COVID-19 is “Airborne AIDS”: provocative oversimplification, emerging science, or something in between?

Desensitization reduces some COVID-19-associated symptoms in minors with allergic rhinitis

The effect of monotherapy versus combination antiviral therapy on all-cause mortality risk in COVID-19 patients

Effectiveness of SARS‐CoV‐2 testing strategies in reducing COVID‐19 cases, hospitalisations, and deaths (new Cochrane review)

Efficacy of novel SARS-CoV-2 vaccines in preventing SARS-CoV- 2 infection: a systematic review and meta-analysis

Enhanced seropositivity and sustained antibody response among healthcare workers: A seroprevalence study during the SARS-CoV-2 pandemic

Exploring Alice in Wonderland syndrome in adults with persistent headache after COVID-19: a cross-sectional study in Latin America

Impact of complement system proteins on the clinical progression of hospitalized patients with COVID-19

Impact of vaccination on SARS-CoV-2 infections and long COVID symptoms: a cross-sectional study in China

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the Omicron era (RECOVER-EHR): a retrospective cohort study

Long COVID in the population of COVID-19 hospitalized patients discharged from SUS’ hospitals in Rio de Janeiro City, Brazil: a patient-engaged cohort survey study

Long-term symptoms after SARS-CoV-2 infection in a cohort of healthcare workers in Qatar

Lymphocyte-to-procalcitonin ratio: a new predictor of prognosis in COVID-19

Multiple detection method for SARS-CoV-2 with aptamer cocktails depending on their localization in paper-based assays

RNA extraction-free CRISPR-based SARS-CoV-2 detection in viral transport medium and dry swab-a comparative analysis

Serum VEGF-A and sVEGFR-1 levels as predictors of disease severity in COVID-19 patients

Sources

AJPM Focus (Oct); BMC Infectious Diseases (30th Sep-13th Oct); BMC Neurology (Oct); Cochrane Library (Oct); Cureus (Sep); Diagnostic Microbiology and Infectious Disease (Nov); Lancet Infectious Diseases (Sep)

October 2025 (1)

Antiviral combination therapy in severely immunocompromised patients with persistent or recurrent COVID-19

Assessing SARS-CoV-2 vaccine effectiveness in health workers: a cohort study conducted during the pandemic decline phase in five hospitals, affiliated to Al-Azhar University, Egypt

Characteristics of Klebsiella pneumoniae and carbapenem-resistant Klebsiella pneumoniae clinical isolates from COVID-19 patients: a single-center retrospective analysis in a tertiary hospital, China

A composite symptoms severity score based on survey self-reports as a predictor of SARS-CoV-2 infection and viral load

Continuing to be cautious: Japanese contact patterns during the COVID-19 pandemic and their association with public health recommendations

Development of SARS-CoV-2 as a viral vector: a novel intranasal bivalent vaccine for SARS-CoV-2 and RSV

The effectiveness of repeated vaccination for COVID-19 symptom resolution during the KP.3-dominant epidemic period in Japan: a retrospective multicenter study

Efficacy of oral antivirals and combination therapy with remdesivir in hematological patients with COVID-19

Evaluating saliva for SARS-CoV-2 detection: a practical alternative

Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and Long COVID: current state and future direction

Long-term impact of COVID-19 in patients with lung cancer receiving immune checkpoint inhibitors: a multicenter cohort study during Omicron pandemic

Long-term physical capacity following COVID-19: a prospective, three-year study

Medical complexity and healthcare utilization among patients attending three U.S. post-COVID clinics

A meta-analysis of vaccine efficacy from phase III clinical trials of approved vaccines against SARS-CoV-2 and variants

Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: a cohort study

Prolonged SARS-CoV-2 nucleic acid detection: clinical characteristics from a US hospital

The quirky story behind New York's SARS-CoV-2 preparations

SARS-CoV-2 PCR and antibody positivity in asymptomatic health care workers with a known SARS-CoV-2 exposure: December, 2020 to December, 2021

Seroprevalence of SARS-CoV-2 antibodies in Ethiopia: findings from the 2022 national population-based survey (second round)

Towards consensus: the need for standardised definitions in Long (post) COVID care in 34 European countries

Sources

American Journal of Infection Control (Oct); BMC Infectious Diseases (16th-29th Sep); Diagnostic Microbiology and Infectious Disease (Oct); European Journal of General Practice (Sep); Frontiers in Cellular and Infection Microbiology (Sep); Journal of Infection (Oct); Journal of Infection and Chemotherapy (Oct); Lancet Infectious Diseases (Oct); PLOS Global Public Health (Sep); Science Advances (Aug-Sep)

Disclaimer

The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.